StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Oral Care (LISTERINE) — Worldwide sales by Year

Oral Care (LISTERINE) — Worldwide sales ($M) ($M)

Johnson & Johnson Oral Care (LISTERINE) — Worldwide sales: $1,505M in FY2022, down 8.5% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2022
1,505
Period ended Jan 1, 2023
Change on a year earlier
-8.5%
1,645 in FY2021
History
7 years
Since FY2016
Sources
4
Documents cited below

Where the FY2022 figure comes from

Source: Form 10-K (filed 2023-02-16) ↗

Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOral Care (LISTERINE) — Worldwide sales ($M) ($M)Year on yearSource
FY2022Jan 1, 20231,505-8.5%Form 10-K (filed 2023-02-16) ↗
FY2021Jan 2, 20221,645+0.2%Form 10-K (filed 2023-02-16) ↗
FY2020Jan 3, 20211,641+7.4%Form 10-K (filed 2023-02-16) ↗
FY2019Dec 29, 20191,528-1.7%Form 10-K (filed 2022-02-17) ↗
FY2018Dec 30, 20181,555+1.6%Form 10-K (filed 2021-02-22) ↗
FY2017Dec 31, 20171,531-2.4%Form 10-K (filed 2019-02-20) ↗
FY2016Jan 1, 20171,568–Form 10-K (filed 2019-02-20) ↗

Breakdown

What makes up oral Care (LISTERINE) — Worldwide sales

Cite this data

StockData. (2026). Johnson & Johnson Oral Care (LISTERINE) — Worldwide sales ($M), annual FY2016–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch-oral-care

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.